VALEANT PHARMACEUTICALS INTL

VRX stock holders 13F

7 superinvestors reported owning VRX (Common Stock) according to the gurus' 2015 Q4 reports.

Top 5 gurus who own (VRX) VALEANT PHARMACEUTICALS INTL

The top 5 super investors (holders) owning VRX (by the percentage (%) of portfolio) are Glenn Greenberg - Brave Warrior Advisors (25.22%), Bill Ackman - Pershing Square Capital Management (13.54%), Jeffrey Ubben - ValueAct Holdings (10.55%), Ole Andreas Halvorsen - Viking Global Investors (2.99%) and Ravenel Boykin Curry IV - Eagle Capital Management (2.92%) as of their 2015 Q4 reports.

To check the latest activities of the top VRX shareholders between value investors, please click on the "Activity" tab.

To see the historical data of VRX's holders please click on the "2015 Q4" dropdown menu and select the date.

# of holders: 7
Period: 2015 Q4
Type: Common Stock
Bill Ackman
13.54%
16,591,122
$101.65
$1,686,488,000
-14.80% (-2,882,811)
-2.35%
Francois Rochon
2.58%
127,735
$101.65
$12,984,000
+1.89% (+2,374)
+0.05%
Glenn Greenberg
25.22%
3,438,782
$101.65
$349,551,950
+12.09% (+370,941)
+2.72%
Jeffrey Ubben
10.55%
14,994,261
$101.65
$1,524,167,000
Ole Andreas Halvorsen
2.99%
7,793,397
$101.65
$792,199,000
+56.08% (+2,800,044)
+1.07%
Ravenel Boykin Curry IV
2.92%
7,034,099
$101.65
$715,016,000
+108.43% (+3,659,378)
+1.52%
Stephen Mandel
2.64%
4,925,571
$101.65
$500,684,470
-21.88% (-1,379,632)
-0.74%
AVG reported hold price*: $101.65

Completely sold out

Nathaniel Simons
1,344,024
-6.56%

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.